Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Taurodeoxycholic acid - Shaperon

Next Previous
Drug Profile

Taurodeoxycholic acid - Shaperon

Alternative Names: HY-209; NuGel®

Latest Information Update: 17 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shaperon
  • Class Anti-inflammatories; Antiseptics; Skin disorder therapies; Small molecules; Sulfonic acids
  • Mechanism of Action GPR19 protein agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Atopic dermatitis
  • Preclinical Idiopathic pulmonary fibrosis; Ulcerative colitis
  • No development reported Sepsis

Most Recent Events

  • 10 Mar 2025 Efficacy and adverse events data from a phase-II clinical trials in Atopic dermatitis released by Shaperon
  • 28 Jan 2025 No recent reports of development identified for phase-I development in Sepsis(In volunteers) in South Korea (IV, Injection)
  • 28 Oct 2024 Preclinical trials in Idiopathic pulmonary fibrosis in South Korea (PO) (Shaperon Pipeline, October 2024)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top